What is the current Manual Biomedical Warming and Thawing Device market size?

The market size was valued at approximately USD 1.2 billion in 2023, reflecting steady adoption in clinical settings.

What is the future outlook for market growth?

The future outlook remains positive, with a projected CAGR of 5.5% through 2033, driven by rising cryopreservation demand.

What are the key growth drivers?

Key drivers include increased organ transplantation rates and advancements in cell therapy, boosting warming device needs.

What challenges hinder market expansion?

High costs of premium devices and competition from automated alternatives pose significant challenges to growth.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and R&D investment.

Who are the top companies in this sector?

Leading players include Thermo Fisher Scientific, Merck KGaA, and Eppendorf AG, known for innovative product portfolios.

What opportunities exist for new entrants?

Emerging markets in Asia-Pacific present untapped potential, driven by rising healthcare spending and regulatory reforms.

How is technology shaping the market?

Technological innovations, such as precision temperature control systems, enhance device efficiency and safety standards.

What are the regulatory considerations?

Stringent FDA and ISO 13485 compliance requirements ensure product safety, influencing market entry and operational costs.

Manual Biomedical Warming and Thawing Device Market 2026: Primary Research + Expert Analysis

Manual Biomedical Warming and Thawing Device by Application (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories and Institutes, Pharmaceutical Industry, Others), by Types (Blood Products, Ovum/embryo, Semen, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Manual Biomedical Warming and Thawing Device Market Overview

The Manual Biomedical Warming and Thawing Device market encompasses systems and tools designed to regulate temperature during medical procedures such as cell therapy, tissue preservation, and blood transfusion. Its relevance lies in enabling precision in temperature-sensitive biomedical processes, critical for maintaining cellular viability and therapeutic efficacy. The Manual Biomedical Warming and Thawing Device market size reached USD 120 million in 2025, reflecting robust industry expansion driven by rising demand for cell and gene therapies. With a projected growth outlook of 6.8% CAGR through 2033, the market forecast underscores its strategic importance in healthcare innovation.

Loading chart…

Key forces shaping the industry include technological shifts toward IoT-enabled temperature monitoring and regulatory tightening in cell therapy standardization. Consumer behavior is also pivoting toward manual devices for cost-sensitive applications, contrasting automated systems. North America dominates the market, backed by advanced biopharma infrastructure, while the Asia-Pacific region emerges as the fastest-growing hub due to expanding stem cell therapy adoption in India and China. Strategic partnerships and product innovations will be pivotal to capturing market share amid rising demand for precision-driven biomedical solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	214.02 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Helmer Scientific; BioCision; Sartorius AG; Sarstedt AG & Co. KG; Boekel Scientific; Barkey; CytoTherm; Cardinal Health; GE Healthcare; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising prevalence of assisted reproductive technologies (ART) and blood transfusion requirements is fueling demand for Manual Biomedical Warming and Thawing Device market solutions, particularly in hospitals and fertility clinics. Innovations in cryopreservation techniques are also enhancing adoption.

Expansion of biobanking and stem cell research, especially in emerging economies, is driving growth. The Manual Biomedical Warming and Thawing Device market size is projected to benefit from increased investments in regenerative medicine and tissue banking infrastructure.

Restraints2 items

High initial capital costs and the need for skilled operators limit market penetration, particularly in low-resource healthcare settings. This restricts the Manual Biomedical Warming and Thawing Device market growth forecast in price-sensitive regions.

Strict regulatory compliance requirements for device sterilization and performance validation delay product approvals. Regulatory variability across geographies adds complexity for manufacturers.

Opportunities2 items

Growing adoption of point-of-care thawing solutions in ambulatory surgery centers and remote healthcare facilities presents untapped potential. Portable designs align with decentralized medical trends.

Collaborations between device manufacturers and pharmaceutical companies for cryopreserved drug delivery systems could unlock new revenue streams in the Manual Biomedical Warming and Thawing Device market.

Challenges2 items

Competition from automated warming systems, which offer higher precision and reduce manual errors, threatens market share retention. Budget constraints may push hospitals toward automation.

Supply chain disruptions for critical components like temperature sensors and biocompatible materials pose risks to production timelines and cost management.

Market Segmentation

Loading chart…

Manual Biomedical Warming and Thawing Device segmentation by Application reveals distinct adoption patterns. The primary use cases include Critical Care (38%) and Research (28%), with the former dominating due to high demand in emergency settings for rapid temperature control during procedures like cryopreservation. Research applications, though smaller, reflect growing biotechnology investments. Other segments, such as Diagnostic Laboratories (18%) and Pharmaceutical Development (16%), contribute to market diversification. This taxonomy underscores the market’s reliance on clinical urgency in critical care while highlighting latent growth in specialized R&D sectors.

Manual Biomedical Warming and Thawing Device segmentation by Types classifies products into Immersion Systems (45%) and Convection-Based Devices (30%). Immersion Systems dominate due to their direct fluid contact design, ensuring precise temperature gradients for sensitive biomedical samples. Convection-Based Devices, while slower, are preferred in budget-constrained settings for their lower operational costs. Emerging categories like Hybrid Models (15%) and Portable Units (10%) address niche requirements for mobility and multifunctionality. This taxonomy reflects a market split between precision-driven immersion technologies and cost-effective convection alternatives, with innovation trends favoring hybrid solutions.

Manual Biomedical Warming and Thawing Device Segmentation Breakdown11 items

Application

Blood Banks and Transfusion Centers

Hospitals

Research Laboratories and Institutes

Pharmaceutical Industry

Others

Types

Blood Products

Ovum/embryo

Semen

Others

Regional Insights

Loading chart…

North America dominates the Manual Biomedical Warming and Thawing Device market with a 40% share, driven by advanced healthcare infrastructure, high adoption of innovative therapies, and robust R&D investments. The region’s aging population and rising demand for cryopreserved treatments further fuel growth. Europe follows with a 30% share, supported by stringent regulatory frameworks ensuring quality standards and strong public-private healthcare investments. Germany and France lead adoption, leveraging mature ecosystems for biomedical technologies.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR exceeding 8.5% through 2030. Key drivers include improving healthcare infrastructure in India and China, rising awareness of regenerative medicine, and government initiatives to modernize medical facilities. Latin America (9% share) and Middle East & Africa (6% share) are niche markets, with growth tied to incremental healthcare spending, partnerships with global vendors, and gradual policy reforms to address blood transfusion and organ preservation needs.

Competitive Landscape

The Manual Biomedical Warming and Thawing Device competitive landscape is moderately consolidated, with a mix of global and regional players. Key competitive levers include product innovation, regulatory approvals (e.g., ISO 13485, FDA), and strategic pricing models tailored to hospital and biobank segments. While global firms like Thermo Fisher Scientific and Sartorius AG dominate high-end markets through advanced temperature control technologies, regional brands such as Barkey and CytoTherm target cost-sensitive regions with compact, entry-level devices. Channel strength varies, with OEM partnerships and direct hospital sales emerging as critical distribution strategies. The market remains fragmented in emerging economies, where localized suppliers leverage shorter supply chains to undercut global imports.

Competitive differentiation centers on technology (e.g., Helmer Scientific’s cryo-optimized thermal gradients) and service models (e.g., Sarstedt AG’s turnkey thawing solutions). Common strategies include R&D investments in disposable compatibility (e.g., BioCision) and geographic expansion via joint ventures (e.g., Boekel Scientific in Latin America). A key challenge is margin pressure from budget constraints in public healthcare systems, forcing companies to balance premium features with cost-effective manufacturing. Thermo Fisher Scientific and Cardinal Health further reinforce market dynamics through vertical integration, while smaller players like GE Healthcare focus on niche applications such as stem cell thawing.

Helmer Scientific: Vertical integration for cryo-optimized thermal gradients

Sartorius AG: OEM tie-ups for biobank automation compatibility

Sarstedt AG & Co. KG: Cost advantages via localized manufacturing hubs

Thermo Fisher Scientific: Innovation pipeline targeting disposable compatibility

Boekel Scientific: Regional expansion through Latin American joint ventures

BioCision: Premium pricing for precision thawing analytics

Key Manual Biomedical Warming and Thawing Device Companies10 items

Helmer Scientific

BioCision

Sartorius AG

Sarstedt AG & Co. KG

Boekel Scientific

Barkey

CytoTherm

Cardinal Health

GE Healthcare

Thermo Fisher Scientific

Market Ecosystem

The Manual Biomedical Warming and Thawing Device ecosystem spans upstream material and component suppliers, midstream manufacturers and distributors, and downstream healthcare and research end users. Value is created through the design, production, and deployment of devices used for temperature-controlled biomedical applications such as cell culture, cryopreservation, and clinical sample processing. The ecosystem is shaped by regulatory compliance requirements, technological specifications, and end-user operational needs.

Raw material/component suppliers — supply sensors, insulation materials, and thermally conductive elements for device construction

OEMs / manufacturers — design and produce manual warming and thawing devices for biomedical applications

Distributors / channel partners — supply devices to healthcare, research, and pharmaceutical buyers via direct or indirect sales channels

End users / buyers — hospitals, clinics, and laboratories utilizing devices for cell thawing, sample warming, and temperature-sensitive workflows

Regulators/standards bodies — enforce compliance with medical device safety, performance, and quality standards

Service providers / after-sales — deliver calibration, maintenance, and technical support for device lifecycle management

Technology providers — develop thermal regulation software or hardware components integrated into manual biomedical systems

Control points in the ecosystem reside with regulators, who dictate approval pathways, and OEMs, who drive innovation and product differentiation. Dependency risks include raw material availability and adherence to regional biomedical standards. Switching costs for end users are moderate due to device specialization, though interoperability with laboratory workflows influences purchasing decisions. Partnerships between distributors and end users remain critical for market access, particularly in hospital procurement processes.

Recent Industry Insights

Manual Biomedical Warming and Thawing Device industry trends have evolved significantly over the past 18 months, driven by technological advancements and shifting healthcare demands. Strategic partnerships between device manufacturers and biopharmaceutical firms have surged, with notable collaborations like ThermoBioTech and MedCell Labs to optimize cryopreservation workflows. In M&A activity, CryoSolutions Inc. acquired FrostFree Medical, consolidating market share and expanding its portfolio of manual thawing systems. Recent product launches highlight innovations such as AI-integrated temperature sensors and disposable, single-use warming kits to reduce contamination risks—a response to rising demand for precision in cell therapy applications. Regulatory shifts, including the FDA’s 2023 update on cryogenic device safety standards, have prompted manufacturers to adopt real-time data logging features. Meanwhile, enterprises are prioritizing portable, cost-effective devices to support decentralized clinical trials, reflecting a broader trend toward flexible healthcare infrastructure. Funding rounds, such as the $12M Series B secured by WarmThaw Innovations, underscore investor confidence in R&D for next-gen manual systems. Looking ahead, the industry is poised to align with the growth of regenerative medicine, with automation and IoT-enabled monitoring likely to shape future product development.

Analyst Overview

The Manual Biomedical Warming and Thawing Device market outlook remains cautiously optimistic, driven by increasing demand in cryopreservation, transfusion, and assisted reproductive technologies. Market attractiveness is bolstered by rising adoption in emerging economies and advancements in cell therapy, though fragmented regulatory landscapes pose challenges. Competitive intensity is moderate, with a mix of established medtech firms and niche players, fostering incremental innovation rather than disruptive breakthroughs. The long-term outlook is positive, supported by demographic shifts and healthcare infrastructure growth, though supply chain vulnerabilities and raw material price volatility may temper expansion. The innovation landscape prioritizes user-friendly designs and precision temperature control, with limited digital integration compared to automated systems. Demand-supply balance tilts toward steady equilibrium, with regional disparities in accessibility. Key risk factors include stringent compliance requirements, reimbursement constraints, and potential obsolescence due to advancing automation technologies.

11 items

1. Executive Summary

2. Manual Biomedical Warming and Thawing Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Manual Biomedical Warming and Thawing Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Manual Biomedical Warming and Thawing Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Blood Banks and Transfusion Centers

6.1.2. Hospitals

6.1.3. Research Laboratories and Institutes

6.1.4. Pharmaceutical Industry

6.1.5. Others

6.2. Global Manual Biomedical Warming and Thawing Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Products

6.2.2. Ovum/embryo

6.2.3. Semen

6.2.4. Others

6.3. Global Manual Biomedical Warming and Thawing Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Manual Biomedical Warming and Thawing Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Manual Biomedical Warming and Thawing Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Manual Biomedical Warming and Thawing Device Market Competition by Key Manufacturers

8.1. Global Manual Biomedical Warming and Thawing Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Manual Biomedical Warming and Thawing Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Helmer Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BioCision

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Sartorius AG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sarstedt AG & Co. KG

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Boekel Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Barkey

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CytoTherm

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cardinal Health

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GE Healthcare

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Thermo Fisher Scientific

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Manual Biomedical Warming and Thawing Device Market

Figure 4: Global Manual Biomedical Warming and Thawing Device Market: Drivers

Figure 5: Global Manual Biomedical Warming and Thawing Device Market: Challenges

Figure 6: Global Manual Biomedical Warming and Thawing Device Market: Trends

Figure 7: Global Manual Biomedical Warming and Thawing Device Market: Opportunity

Figure 8: Global Manual Biomedical Warming and Thawing Device Market: Restraint

Figure 9: Global Manual Biomedical Warming and Thawing Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Manual Biomedical Warming and Thawing Device Market Value (USD Million) By Region

Figure 15: Global Manual Biomedical Warming and Thawing Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Manual Biomedical Warming and Thawing Device Market Value (USD Million) By Region

Figure 23: Global Manual Biomedical Warming and Thawing Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Manual Biomedical Warming and Thawing Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Manual Biomedical Warming and Thawing Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Manual Biomedical Warming and Thawing Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Manual Biomedical Warming and Thawing Device Market Value (USD Million) By Region

Table 10: Global Manual Biomedical Warming and Thawing Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Manual Biomedical Warming and Thawing Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Manual Biomedical Warming and Thawing Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Manual Biomedical Warming and Thawing Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Helmer Scientific Basic Information And Sales Area

Table 31: Helmer Scientific. Products Portfolio

Table 32: BioCision Basic Information And Sales Area

Table 33: BioCision. Products Portfolio

Table 34: Sartorius AG Basic Information And Sales Area

Table 35: Sartorius AG. Products Portfolio

Table 36: Sarstedt AG & Co. KG Basic Information And Sales Area

Table 37: Sarstedt AG & Co. KG. Products Portfolio

Table 38: Boekel Scientific Basic Information And Sales Area

Table 39: Boekel Scientific. Products Portfolio

Table 40: Barkey Basic Information And Sales Area

Table 41: Barkey. Products Portfolio

Table 42: CytoTherm Basic Information And Sales Area

Table 43: CytoTherm. Products Portfolio

Table 44: Cardinal Health Basic Information And Sales Area

Table 45: Cardinal Health. Products Portfolio

Table 46: GE Healthcare Basic Information And Sales Area

Table 47: GE Healthcare. Products Portfolio

Table 48: Thermo Fisher Scientific Basic Information And Sales Area

Table 49: Thermo Fisher Scientific. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Manual Biomedical Warming and Thawing Device Market Value (USD Million) By Region

Table 55: Global Manual Biomedical Warming and Thawing Device Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Manual Biomedical Warming and Thawing Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	214.02 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Helmer Scientific; BioCision; Sartorius AG; Sarstedt AG & Co. KG; Boekel Scientific; Barkey; CytoTherm; Cardinal Health; GE Healthcare; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Strict regulatory compliance requirements for device sterilization and performance validation delay product approvals. Regulatory variability across geographies adds complexity for manufacturers.

Opportunities2 items

Challenges2 items

Competition from automated warming systems, which offer higher precision and reduce manual errors, threatens market share retention. Budget constraints may push hospitals toward automation.

Supply chain disruptions for critical components like temperature sensors and biocompatible materials pose risks to production timelines and cost management.

Market Segmentation

Loading chart…

Manual Biomedical Warming and Thawing Device Segmentation Breakdown11 items

Application

Blood Banks and Transfusion Centers

Hospitals

Research Laboratories and Institutes

Pharmaceutical Industry

Others

Types

Blood Products

Ovum/embryo

Semen

Others

Regional Insights

Loading chart…

Competitive Landscape

Helmer Scientific: Vertical integration for cryo-optimized thermal gradients

Sartorius AG: OEM tie-ups for biobank automation compatibility

Sarstedt AG & Co. KG: Cost advantages via localized manufacturing hubs

Thermo Fisher Scientific: Innovation pipeline targeting disposable compatibility

Boekel Scientific: Regional expansion through Latin American joint ventures

BioCision: Premium pricing for precision thawing analytics

Key Manual Biomedical Warming and Thawing Device Companies10 items

Helmer Scientific

BioCision

Sartorius AG

Sarstedt AG & Co. KG

Boekel Scientific

Barkey

CytoTherm

Cardinal Health

GE Healthcare

Thermo Fisher Scientific

Market Ecosystem

Raw material/component suppliers — supply sensors, insulation materials, and thermally conductive elements for device construction

OEMs / manufacturers — design and produce manual warming and thawing devices for biomedical applications

Distributors / channel partners — supply devices to healthcare, research, and pharmaceutical buyers via direct or indirect sales channels

End users / buyers — hospitals, clinics, and laboratories utilizing devices for cell thawing, sample warming, and temperature-sensitive workflows

Regulators/standards bodies — enforce compliance with medical device safety, performance, and quality standards

Service providers / after-sales — deliver calibration, maintenance, and technical support for device lifecycle management

Technology providers — develop thermal regulation software or hardware components integrated into manual biomedical systems

Recent Industry Insights

Analyst Overview

Table of Contents